Thrivent Financial for Lutherans increased its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 21.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,303 shares of the medical technology company's stock after buying an additional 3,736 shares during the period. Thrivent Financial for Lutherans' holdings in Teleflex were worth $5,269,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of TFX. Cromwell Holdings LLC increased its position in Teleflex by 59.0% during the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company's stock worth $33,000 after purchasing an additional 49 shares during the last quarter. Ashton Thomas Securities LLC acquired a new stake in shares of Teleflex during the 3rd quarter worth $40,000. Canada Pension Plan Investment Board purchased a new position in shares of Teleflex in the 2nd quarter worth $42,000. GAMMA Investing LLC boosted its holdings in Teleflex by 131.1% in the third quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company's stock valued at $42,000 after acquiring an additional 97 shares during the last quarter. Finally, Versant Capital Management Inc increased its stake in Teleflex by 20,700.0% during the second quarter. Versant Capital Management Inc now owns 208 shares of the medical technology company's stock worth $44,000 after acquiring an additional 207 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company's stock.
Analyst Ratings Changes
TFX has been the topic of a number of research reports. Truist Financial reissued a "hold" rating and issued a $227.00 target price (down previously from $255.00) on shares of Teleflex in a research note on Monday, November 4th. StockNews.com downgraded Teleflex from a "buy" rating to a "hold" rating in a research report on Wednesday. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a research report on Friday, November 1st. Mizuho lowered their price objective on shares of Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a research report on Friday, November 1st. Finally, Stephens boosted their target price on shares of Teleflex from $275.00 to $290.00 and gave the stock an "overweight" rating in a research report on Friday, August 2nd. Four analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $259.25.
View Our Latest Stock Analysis on Teleflex
Teleflex Stock Performance
TFX stock traded up $1.07 during mid-day trading on Friday, reaching $191.71. The company had a trading volume of 309,439 shares, compared to its average volume of 552,117. The stock's 50-day simple moving average is $224.99 and its two-hundred day simple moving average is $222.88. The stock has a market capitalization of $8.90 billion, a P/E ratio of 38.11, a P/E/G ratio of 1.95 and a beta of 1.18. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a one year low of $185.66 and a one year high of $257.85.
Teleflex (NYSE:TFX - Get Free Report) last posted its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $764.40 million during the quarter, compared to analyst estimates of $768.68 million. During the same period in the previous year, the business posted $3.64 EPS. Teleflex's revenue was up 2.4% on a year-over-year basis. Research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.
Teleflex Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Friday, November 15th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.36 dividend on an annualized basis and a yield of 0.71%. Teleflex's dividend payout ratio (DPR) is presently 27.04%.
Teleflex Company Profile
(
Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Recommended Stories
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.